diagnostic screening programs

The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study
Mauro Scimia, Francesco Pepe, Gianluca Russo, Lucia Palumbo, Umberto Malapelle, Rachel Chuang, Simone Scimia, Michael Sha, Hiromi Tanaka, Shuo Shen, David Chen, Giancarlo Troncone, Maria Antonia Bianco

Journal of Clinical Pathology Apr 2024, jcp-2024-209527; DOI: 10.1136/jcp-2024-209527
Recently described types of dysplasia associated with IBD: tips and clues for the practising pathologist
Zahra Alipour, Kristen Stashek

Journal of Clinical Pathology Feb 2024, 77 (2) 77-81; DOI: 10.1136/jcp-2023-209141
Improving the management of early colorectal cancers (eCRC) by using quantitative markers to predict lymph node involvement and thus the need for major resection of pT1 cancers
Scarlet Brockmoeller, Eu-Wing Toh, Katerina Kouvidi, Sarah Hepworth, Eva Morris, Philip Quirke

Journal of Clinical Pathology Aug 2022, 75 (8) 545-550; DOI: 10.1136/jclinpath-2021-207482
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework
Ramya Bhatia, Elia Alcaniz Boada, Jesper Hansen Bonde, Wim G V Quint, Lan Xu, Ditte Moller Ejegod, Kate Cuschieri, Marc Arbyn

Journal of Clinical Pathology Mar 2023, 76 (3) 172-176; DOI: 10.1136/jclinpath-2021-207864
Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients
Emmanuel Khalifa, Caroline Chapusot, Benjamin Tournier, Julie Sentis, Estelle Marion, Alicia Remond, Manon Aubry, Célia Pioche, Anthony Bergeron, Charlotte Primois, Larry Blanchard, Alice Millière, Marlène Boucheix, Yannick Léger, Marine Bairrao, Véronique Brouste, Laurent Martin, Isabelle Soubeyran

Journal of Clinical Pathology Oct 2023, 76 (10) 698-704; DOI: 10.1136/jcp-2022-208325
BCR::ABL1 screening is not indicated in patients with splenomegaly without neutrophilia and/or basophilia
Stephen E Langabeer

Journal of Clinical Pathology Jun 2023, 76 (6) 413; DOI: 10.1136/jcp-2023-208864
Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer
Jenny Fitzgerald, Debra Higgins, Claudia Mazo Vargas, William Watson, Catherine Mooney, Arman Rahman, Niamh Aspell, Amy Connolly, Claudia Aura Gonzalez, William Gallagher

Journal of Clinical Pathology Jul 2021, 74 (7) 429-434; DOI: 10.1136/jclinpath-2020-207351
Why is the novel Hb Miguel Servet visualised by CE-HPLC newborn and not by the CE-HPLC β-thalassaemia programme?
Valle Recasens, Ángeles Montañés, Carmen Rodríguez-Vigil, Yolanda González, Guillermo Hernández de Abajo, Jorge M Nieto, Beatriz González Fernández, Fernando-Ataúlfo González-Fernández, Ana Villegas, Celina Benavente, Paloma Ropero

Journal of Clinical Pathology Mar 2021, 74 (3) 198-201; DOI: 10.1136/jclinpath-2020-206812

Log in using your username and password

Main menu

Log in using your username and password

You are here

diagnostic screening programs